Editorial: Translational research in thyroid cancer, Volume II.
作者信息
Cheng Sheue-Yann, Vasko Vasyl, Jensen Kirk Ernest
机构信息
Laboratory of Molecular Biology, National Cancer Institute, Bethesda, MD, United States.
Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.
出版信息
Front Endocrinol (Lausanne). 2023 Jun 13;14:1223976. doi: 10.3389/fendo.2023.1223976. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Translational research in thyroid cancer, Volume II.
Front Endocrinol (Lausanne). 2023 Jun 13;14:1223976. doi: 10.3389/fendo.2023.1223976. eCollection 2023.
2
Editorial: Translational Research in Thyroid Cancer.
Front Endocrinol (Lausanne). 2020 Apr 15;11:224. doi: 10.3389/fendo.2020.00224. eCollection 2020.
3
Oncogenes in thyroid cancer.
Clin Otolaryngol Allied Sci. 2003 Oct;28(5):386-95. doi: 10.1046/j.1365-2273.2003.00732.x.
4
Oncogenes, mitochondrial metabolism, and quality control in differentiated thyroid cancer.
Korean J Intern Med. 2017 Sep;32(5):780-789. doi: 10.3904/kjim.2016.420. Epub 2017 Aug 22.
5
American Thyroid Association guidelines for management of medullary thyroid cancer: an adult endocrinology perspective.
Thyroid. 2009 Jun;19(6):547-50. doi: 10.1089/thy.2009.0147.
6
Molecular mechanisms in differentiated thyroid cancer.
Front Biosci (Landmark Ed). 2016 Jan 1;21(1):119-29. doi: 10.2741/4379.
7
Editorial: Double-edged swords: important factors connecting metabolic disorders and cancer development - from basic research to translational applications, volume II.
Front Endocrinol (Lausanne). 2024 Jun 19;15:1441828. doi: 10.3389/fendo.2024.1441828. eCollection 2024.
8
Molecular pathogenesis of thyroid cancer: the significance of oncogenes, tumor suppressor genes, and genomic instability.
Exp Clin Endocrinol Diabetes. 1996;104 Suppl 4:1-12. doi: 10.1055/s-0029-1211691.
9
Progress in molecular-based management of differentiated thyroid cancer.
Lancet. 2013 Mar 23;381(9871):1058-69. doi: 10.1016/S0140-6736(13)60109-9. Epub 2013 Mar 22.
10
[Gene abnormalities in thyroid cancer].
Nihon Rinsho. 2007 Nov;65(11):1967-72.
本文引用的文献
1
Thyroid cancer incidence trends by histology in 25 countries: a population-based study.
Lancet Diabetes Endocrinol. 2021 Apr;9(4):225-234. doi: 10.1016/S2213-8587(21)00027-9. Epub 2021 Mar 1.
2
Radiation Exposure to the Thyroid After the Chernobyl Accident.
Front Endocrinol (Lausanne). 2021 Jan 5;11:569041. doi: 10.3389/fendo.2020.569041. eCollection 2020.
3
Cancers after Chornobyl: From Epidemiology to Molecular Quantification.
Cancers (Basel). 2019 Sep 2;11(9):1291. doi: 10.3390/cancers11091291.
4
Gilbert W. Beebe Symposium on 30 Years after the Chernobyl Accident: Current and Future Studies on Radiation Health Effects.
Radiat Res. 2018 Jan;189(1):5-18. doi: 10.1667/RR14791.1. Epub 2017 Nov 14.
5
6
BRAF(V600E) and microenvironment in thyroid cancer: a functional link to drive cancer progression.
Cancer Res. 2011 Apr 1;71(7):2417-22. doi: 10.1158/0008-5472.CAN-10-3844. Epub 2011 Mar 29.
7
A cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident: thyroid cancer in Ukraine detected during first screening.
J Natl Cancer Inst. 2006 Jul 5;98(13):897-903. doi: 10.1093/jnci/djj244.
Zotero 插件